INO:NASDAQ
Inovio Pharmaceuticals Inc
1,41 $
arrow_downward
-1,40%(-0,020) 1D
16 қар., 13:56:41 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,42 $
High
1,48 $
Low
1,37 $
Mkt. cap
264,10 млн
Avg. vol.
19,34 млн
Volume
3,87 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Open
1,42 $
High
1,48 $
Low
1,37 $
Mkt. cap
264,10 млн
Avg. vol.
19,34 млн
Volume
3,87 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
The Korea Times
·
55 минут бұрын
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 сағат бұрын
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
2 сағат бұрын
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
Stocktwits
·
1 сағат бұрын
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc